Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | ADMA BIOLOGICS, INC. | Kestenberg-Messin...
(COO and SVP, Compliance) |
F | Common Stock | D | 2085 | $6.60 - $6.60 | $13,761 |
| 2024-04-01 | ADMA BIOLOGICS, INC. | Kestenberg-Messin...
(COO and SVP, Compliance) |
A | Common Stock | A | 192320 | $0.00 - $0.00 | $0 |
| 2024-03-31 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President,CEO, and Interim CFO) |
F | Common Stock | D | 21752 | $6.60 - $6.60 | $143,563 |
| 2024-03-18 | ADMA BIOLOGICS, INC. | ELMS STEVE
(Director) |
S | Common Stock | D | 461716 | $6.01 - $6.08 | $2,803,740 |
| 2024-03-13 | ADMA BIOLOGICS, INC. | ELMS STEVE
(Director) |
S | Common Stock | D | 1038284 | $6.01 - $6.21 | $6,339,417 |
| 2024-03-06 | ADMA BIOLOGICS, INC. | LENZ BRIAN
(EVP, CFO) |
F | Common Stock | D | 33642 | $6.12 - $6.16 | $206,567 |
| 2024-03-06 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President and CEO) |
F | Common Stock | D | 83766 | $6.12 - $6.16 | $513,798 |
| 2024-02-29 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President and CEO) |
F | Common Stock | D | 9588 | $5.36 - $5.36 | $51,391 |
| 2024-02-29 | ADMA BIOLOGICS, INC. | LENZ BRIAN
(EVP, CFO) |
F | Common Stock | D | 4935 | $5.36 - $5.36 | $26,451 |
| 2024-02-26 | ADMA BIOLOGICS, INC. | FINGER ALISON CECILY
(Director) |
A | Common Stock | A | 24040 | $0.00 - $0.00 | $0 |
| 2024-02-26 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President and CEO) |
A | Common Stock | A | 557728 | $0.00 - $0.00 | $0 |
| 2024-02-26 | ADMA BIOLOGICS, INC. | Grossman Jerrold B
(Director) |
A | Common Stock | A | 24040 | $0.00 - $0.00 | $0 |
| 2024-02-26 | ADMA BIOLOGICS, INC. | KWON YOUNG
(Director) |
A | Common Stock | A | 24040 | $0.00 - $0.00 | $0 |
| 2024-02-26 | ADMA BIOLOGICS, INC. | Guiheen Lawrence P.
(Director) |
A | Common Stock | A | 24040 | $0.00 - $0.00 | $0 |
| 2024-02-26 | ADMA BIOLOGICS, INC. | ELMS STEVE
(Director) |
A | Common Stock | A | 24040 | $0.00 - $0.00 | $0 |
| 2024-02-25 | ADMA BIOLOGICS, INC. | LENZ BRIAN
(EVP, CFO) |
F | Common Stock | D | 8257 | $5.26 - $5.26 | $43,431 |
| 2024-02-25 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President and CEO) |
F | Common Stock | D | 22457 | $5.26 - $5.26 | $118,123 |
| 2023-12-31 | ADMA BIOLOGICS, INC. | LENZ BRIAN
(EVP, CFO) |
F | Common Stock | D | 16908 | $4.52 - $4.52 | $76,424 |
| 2023-12-31 | ADMA BIOLOGICS, INC. | LENZ BRIAN
(EVP, CFO) |
F | Common Stock | D | 16908 | $4.52 - $4.52 | $76,424 |
| 2023-12-31 | ADMA BIOLOGICS, INC. | Grossman Adam S
(President and CEO) |
F | Common Stock | D | 23057 | $4.52 - $4.52 | $104,217 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |